114 related articles for article (PubMed ID: 8449205)
1. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
Pacher R; Globits S; Bergler-Klein J; Teufelsbauer H; Wutte M; Baumgartner W; Ogris E; Glogar D
Eur Heart J; 1993 Feb; 14(2):273-8. PubMed ID: 8449205
[TBL] [Abstract][Full Text] [Related]
2. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
[TBL] [Abstract][Full Text] [Related]
3. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
Rouleau JL; Packer M; Moyé L; de Champlain J; Bichet D; Klein M; Rouleau JR; Sussex B; Arnold JM; Sestier F
J Am Coll Cardiol; 1994 Sep; 24(3):583-91. PubMed ID: 7915733
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
Schofer J; Hobuss M; Aschenberg W; Tews A
Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
[TBL] [Abstract][Full Text] [Related]
6. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
[TBL] [Abstract][Full Text] [Related]
7. The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
Jansson K; Dahlström U; Karlberg BE; Karlsson E; Nylander E; Nyquist O; Karlberg KE
J Intern Med; 1999 May; 245(5):435-43. PubMed ID: 10363743
[TBL] [Abstract][Full Text] [Related]
8. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
9. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
[TBL] [Abstract][Full Text] [Related]
10. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
Rouleau JL; Kortas C; Bichet D; de Champlain J
Am Heart J; 1988 Sep; 116(3):746-57. PubMed ID: 2970771
[TBL] [Abstract][Full Text] [Related]
11. Intravenous captopril in congestive heart failure.
Ahmad S; Giles TD; Roffidal LE; Haney Y; Given MB; Sander GE
J Clin Pharmacol; 1990 Jul; 30(7):609-14. PubMed ID: 2202753
[TBL] [Abstract][Full Text] [Related]
12. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of congestive heart failure with captopril.
Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
[TBL] [Abstract][Full Text] [Related]
14. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
Dahlström U; Karlberg BE
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
Benatar D; Hall V; Reddy S; Gheorghiade M
Am J Ther; 1998 Jan; 5(1):25-32. PubMed ID: 10099034
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
[TBL] [Abstract][Full Text] [Related]
18. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of low dose captopril versus propranolol therapy in infants with severe congestive failure due to left-to-right shunts.
Buchhorn R; Ross RD; Hulpke-Wette M; Bartmus D; Wessel A; Schulz R; Bürsch J
Int J Cardiol; 2000; 76(2-3):227-33. PubMed ID: 11104878
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
